Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GUSB pseudogene 16 (GUSBP16) is one of multiple pseudogenes related to the GUSB (Glucuronidase beta) gene present within the human genome[1][4]. Pseudogenes like GUSBP16 arise from gene duplication or retrotransposition events but acquire mutations that prevent them from coding for a functional protein product[4]. There is no published evidence that GUSBP16 is transcribed or that it has any regulatory or pathophysiological significance. Pseudogenes may sometimes be transcribed or have noncoding RNA roles, but no such evidence exists for GUSBP16 specifically[4][6]. Consequently, there are no known drugs, biomarkers, safety concerns, or molecular functions associated with this pseudogene. If you are seeking information about the *functional* GUSB gene (Glucuronidase beta), that is a lysosomal enzyme involved in glycosaminoglycan degradation and linked to mucopolysaccharidosis type VII[1][2][3][5]; however, GUSBP16 is a non-functional pseudogene related to this locus and currently not a target of therapeutic interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GUSB pseudogene 16 (GUSBP16).